Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial

Evidence for neoadjuvant chemotherapy combined with targeted therapy for locally advanced esophageal squamous cancer (ESCC) is inadequate. We conducted a single-arm phase II trial to evaluate the efficacy and safety of apatinib combined with taxol and cisplatin (ATP) for locally advanced ESCC. All p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bo, Guo, Xiaofeng, Le, Cheng, Su, Wenzhong, Li, Xiaoming, Zhang, Yanfeng, Yang, Guangyi, Liang, Weimin, Zheng, Zhixin, Wu, Junpeng, Zhang, Yaowen, Hao, Anlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313985/
https://www.ncbi.nlm.nih.gov/pubmed/35898681
http://dx.doi.org/10.1155/2022/4727407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313985/
https://www.ncbi.nlm.nih.gov/pubmed/35898681
http://dx.doi.org/10.1155/2022/4727407

Ejemplares similares